For example, GLUT1 upregulation is a consequence of YAP activation in both breast and gastric cancer and has been correlated with BCL-xL expression in colorectal and gastric cancer (Wincewicz et al., 2007; Lin and Xu, 2017; Li et al., 2019a). Here, BCL2L1 is linked to gastric cancer.